Correlation Between Abbott Laboratories and Stryker

Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and Stryker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and Stryker into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abbott Laboratories and Stryker, you can compare the effects of market volatilities on Abbott Laboratories and Stryker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of Stryker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and Stryker.

Diversification Opportunities for Abbott Laboratories and Stryker

0.85

Correlation Coefficient

Abbott Laboratories  Stryker

Very poor diversification

The 3 months correlation between Abbott and Stryker is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and Stryker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stryker and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with Stryker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stryker has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and Stryker go up and down completely randomly.

Pair Corralation between Abbott Laboratories and Stryker

Assuming the 90 days horizon Abbott Laboratories is expected to generate 0.45 times more return on investment than Stryker. However, Abbott Laboratories is 2.22 times less risky than Stryker. It trades about -0.26 of its potential returns per unit of risk. Stryker is currently generating about -0.25 per unit of risk. If you would invest  11,224  in Abbott Laboratories on September 23, 2024 and sell it today you would lose (418.00) from holding Abbott Laboratories or give up 3.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Abbott Laboratories  vs.  Stryker

Abbott Laboratories

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Abbott Laboratories may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Stryker

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Stryker is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Abbott Laboratories and Stryker

The main advantage of trading using opposite Abbott Laboratories and Stryker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, Stryker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stryker will offset losses from the drop in Stryker's long position.

The idea behind Abbott Laboratories and Stryker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.